Investment
Features
FeesSafety
Academy
More
Pluang+

Compare iShares Silver Trust (SLV) vs Health Care Select Sector SPDR Fund (XLV) Price & Performance

iShares Silver TrustTrade
Health Care Select Sector SPDR FundTrade

Price performance (Past 24H)

Key statistics

iShares Silver Trust vs Health Care Select Sector SPDR Fund — how do they compare? iShares Silver Trust trades at $54.23, while Health Care Select Sector SPDR Fund trades at $160.19. The key difference: Health Care Select Sector SPDR Fund is trading nearer its 52-week high, iShares Silver Trust nearer its low. Which is the better fit depends on your goals.

SLVXLV
52-Week High
$105.57$164.48
52-Week Low
$33.32$129.01

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

iShares Silver Trust

SLV, the iShares Silver Trust ETF, trades at $53.08, up 4.53% on the day, amid a broader precious metals rebound. Technical indicators are predominantly bearish, with moving averages signaling sell pressure, though short-term RSI suggests potential oversold conditions. Recent news highlights silver's sensitivity to interest rate expectations and geopolitical tensions, with supply deficits and industrial demand providing fundamental support. The ETF lacks traditional valuation metrics like P/E or P/B as it tracks physical silver.

The outlook for SLV hinges on macroeconomic factors, including Fed policy and silver's dual role as a monetary and industrial metal. Risks include persistent rate hikes and dollar strength, but long-term demand drivers offer appreciation potential. Investors should weigh silver's volatility against its hedge attributes.

Health Care Select Sector SPDR Fund

XLV trades at $159.25, down 1.14% with neutral technical signals overall. The healthcare ETF shows mixed momentum with bullish moving averages but neutral oscillators. Recent news highlights XLV's defensive characteristics amid market volatility, with State Street upgrading healthcare to positive for Q3 2026. The fund's diversified approach offers stability compared to more volatile biotech-focused alternatives.

XLV presents a defensive opportunity with lower costs and steady performance, though upside may be limited in the current cycle. Key risks include patent cliff concerns and sector rotation away from defensive plays if market sentiment improves. The ETF's broad healthcare exposure provides cushion against individual stock volatility while benefiting from pipeline innovations.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About iShares Silver Trust

The ETF seeks to reflect such performance before payment of the ETF's expenses and liabilities. It is not actively managed. The ETF does not engage in any activities designed to obtain a profit from, or to ameliorate losses caused by, changes in the price of silver.

Read more on SLV

About Health Care Select Sector SPDR Fund

In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.

Read more on XLV